Skip to content
★ Sign in to follow
DO

David Owens

Nexalin Technology, Inc.
Insider activity · 24 months4 buys0 salesCumulative net flow
Total declarations
13
Company
1
▲ Purchases (12 ops.)
€34k
▼ Sales (0 ops.)
—

Latest filing published 30 Sept 2025 for Nexalin Technology, Inc..

Filing timeline

BuySale
David Owens

Insider track record

Disclosed buys
12
Disclosed sells
0
Signal history

Closed purchases

Market purchases
10
Positive at T+90
0%
Median T+90
-50.8%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

David Owens: trading record in brief

David Owens is a declared insider of Nexalin Technology, Inc., with filings sourced from SEC (Form 4). Between 16 September 2022 and 29 September 2025, the trades on record add up to 13 filings.

On the market, this insider has only ever bought: 12 purchases, €34k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant. Since January 2025: 5 purchases and no sales on the market.

A typical purchase (the median) is worth €2,114. Of 12 purchases, 1 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 4 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -50.8%. This is a record of the past, not a forecast.

The record was last updated on 30 September 2025 with a share grant in Nexalin Technology, Inc. The last insider purchase was made public on 5 February 2025, 641 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to David Owens

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total
  • ◆
    Chief Medical OfficerExecutivesNexalin Technology, Inc.
    0SEC
    36,459 shares0Common stockSEC:0001829126-25-007777:0
  • ▲
    Chief Medical OfficerExecutivesNexalin Technology, Inc.
    3,100 USD18SEC
    1,000 shares@ US$3.109.7% of flowCommon stockSEC:0001829126-25-000724:0
    Canonical exit: 5 May 2025 (T+90)
  • ▲
    Chief Medical OfficerExecutivesNexalin Technology, Inc.
    2,980 USD18SEC
    1,000 shares@ US$2.989.4% of flowCommon stockSEC:0001829126-25-000672:0
    Canonical exit: 5 May 2025 (T+90)
  • ▲
    Chief Medical OfficerExecutivesNexalin Technology, Inc.
    4,050 USD18SEC
    1,500 shares@ US$2.7012.6% of flowCommon stockSEC:0001829126-25-000542:0
    Canonical exit: 28 Apr 2025 (T+90)
  • ▲
    Chief Medical OfficerExecutivesNexalin Technology, Inc.
    5,000 USD19SEC
    2,000 shares@ US$2.5015.8% of flowCommon stockSEC:0001829126-25-000368:0
    Canonical exit: 13 Apr 2025 (T+90)
  • ▲
    Chief Medical OfficerExecutivesNexalin Technology, Inc.
    1,095 USD17SEC
    500 shares@ US$2.193.3% of flowCommon stockSEC:0001829126-24-007091:0
    Canonical exit: 26 Jan 2025 (T+90)
  • ▲
    Chief Medical OfficerExecutivesNexalin Technology, Inc.
    950 USD17SEC
    1,000 shares@ US$0.952.8% of flowCommon stockSEC:0001829126-24-005573:0
    Canonical exit: 11 Nov 2024 (T+90)
  • ▲
    Chief Medical OfficerExecutivesNexalin Technology, Inc.
    1,750 USD16SEC
    1,000 shares@ US$1.755.3% of flowCommon stockSEC:0001829126-24-004517:0
    Canonical exit: 26 Sept 2024 (T+90)
  • ▲
    Chief Medical OfficerExecutivesNexalin Technology, Inc.
    1,149 USD13SEC
    1,619 shares@ US$0.713.5% of flowCommon stockSEC:0001829126-24-004353:0
    Canonical exit: 16 Sept 2024 (T+90)
  • ▲
    Chief Medical OfficerExecutivesNexalin Technology, Inc.
    1,300 USD11SEC
    2,000 shares@ US$0.653.9% of flowCommon stockSEC:0001829126-24-004108:0
    Canonical exit: 8 Sept 2024 (T+90)
  • ▲
    Chief Medical OfficerExecutivesNexalin Technology, Inc.
    10,375 USD32SEC
    2,500 shares@ US$4.1533.7% of flowCommon StockSEC:0001829126-22-017005:0
    Canonical exit: 15 Dec 2022 (T+90)

11 of 11 declarations